(Q53286025)

13 May 2018

title

A decision chart for assessing and improving the transferability of economic evaluation results between countries. (English)

1 reference

13 May 2018

author

Talitha L. Feenstra

2

1 reference

13 May 2018

author name string

Robert Welte

1

1 reference

13 May 2018

Hans Jager

3

1 reference

13 May 2018

Reiner Leidl

4

1 reference

13 May 2018

publication date

1 January 2004

1 reference

13 May 2018

published in

PharmacoEconomics

1 reference

13 May 2018

volume

22

1 reference

13 May 2018

issue

13

1 reference

13 May 2018

page(s)

857-876

1 reference

13 May 2018

https://scigraph.springernature.com/pub.10.2165/00019053-200422130-00004

exact match

0 references

cites work

Making cost assessments based on RCTs more useful to decision-makers

1 reference

12 December 2020

Estimating country-specific cost-effectiveness from multinational clinical trials

1 reference

12 December 2020

An international study of patient compliance with hemodialysis

1 reference

12 December 2020

Pharmacoeconomic evaluation in the real world. Effectiveness versus efficacy studies

1 reference

12 December 2020

Report from the Canadian Coordinating Office for Health Technology Assessment (CCOHTA). Guidelines for economic evaluation of pharmaceuticals: Canada

1 reference

12 December 2020

The relation between surgical volume and mortality: an exploration of causal factors and alternative models.

1 reference

12 December 2020

Economics of elective coronary revascularization. Comparison of costs and charges for conventional angioplasty, directional atherectomy, stenting and bypass surgery.

1 reference

12 December 2020

Economic analysis of tirilazad mesylate for aneurysmal subarachnoid hemorrhage. Economic evaluation of a phase III clinical trial in Europe and Australia

1 reference

12 December 2020

Extrapolation of cost-effectiveness information to local settings

1 reference

12 December 2020

[German recommendations for health care economic evaluation studies. Revised version of the Hannover consensus. Hannover Consensus Group]

1 reference

12 December 2020

Some factors to consider when using the results of economic evaluation studies at the population level.

1 reference

12 December 2020

Differences in care-seeking behavior for acute chest pain in the United States and Japan

1 reference

12 December 2020

How cost-effective is the treatment of dyslipidemia in patients with diabetes but without cardiovascular disease?

1 reference

12 December 2020

Decision analytic modelling in the economic evaluation of health technologies. A consensus statement. Consensus Conference on Guidelines on Economic Modelling in Health Technology Assessment

1 reference

12 December 2020

Outcome of total hip replacement in Japan and England. Comparison of two retrospective cohorts

1 reference

12 December 2020

Analyzing differences in the costs of treatment across centers within economic evaluations.

1 reference

12 December 2020

The generalisability of pharmacoeconomic studies

1 reference

12 December 2020

The impact of age on cost-effectiveness ratios and its control in decision making

1 reference

12 December 2020

A practical guide for calculating indirect costs of disease

1 reference

12 December 2020

Good technologies gone bad: how and why the cost-effectiveness of a medical intervention changes for different populations.

1 reference

12 December 2020

Timing of adoption of laparoscopic cholecystectomy in Denmark and in The Netherlands: a comparative study.

1 reference

12 December 2020

Handling uncertainty in cost-effectiveness models

1 reference

12 December 2020

Meta-analysis, clinical trials, and transferability of research results into practice. The case of cholesterol-lowering interventions in the secondary prevention of coronary heart disease

1 reference

12 December 2020

Economic Analysis Alongside Clinical Trials: Revisiting the Methodological Issues

1 reference

12 December 2020

A re-examination of the meaning and importance of supplier-induced demand

1 reference

12 December 2020

Economic evaluation of pharmaceuticals. Frankenstein's monster or vampire of trials?

1 reference

12 December 2020

Should operations be regionalized? The empirical relation between surgical volume and mortality

1 reference

12 December 2020

Issues in extrapolating from clinical trials to clinical practice and outcomes

1 reference

12 December 2020

Real world designs in economic evaluation. Bridging the gap between clinical research and policy-making

1 reference

12 December 2020

Cost-effectiveness analysis: can we reduce variability in costing methods?

1 reference

12 December 2020

Methodological hurdles in conducting pharmacoeconomic analyses

1 reference

12 December 2020

Customising an international disease management model to the needs of individual countries. Application to upper gastrointestinal disease

1 reference

12 December 2020

Effects of surgeon volume and hospital volume on quality of care in hospitals

1 reference

12 December 2020

New Perspectives on the Cost-Effectiveness of Palmaz-Schatzª Coronary Stenting, Balloon Angioplasty, and Coronary Artery Bypass Surgery Ñ A Decision Model Analysis

1 reference

12 December 2020

Does prospective payment reduce inpatient length of stay?

1 reference

12 December 2020

The volume-outcome relationship: practice-makes-perfect or selective-referral patterns?

1 reference

12 December 2020

Economic evaluation of vaccination programs: the impact of herd-immunity

1 reference

12 December 2020

Do competition and managed care improve quality?

1 reference

12 December 2020

Herd immunity: history, theory, practice

1 reference

12 December 2020

Cost-effectiveness analysis of formoterol versus salmeterol in patients with asthma.

1 reference

12 December 2020

Variations in resource utilization among medical specialties and systems of care. Results from the medical outcomes study.

1 reference

12 December 2020

Cost-effectiveness of screening programs for Chlamydia trachomatis: a population-based dynamic approach

1 reference

12 December 2020

Economic evaluations in the critical care literature: do they help us improve the efficiency of our unit?

1 reference

12 December 2020

Estimating an EQ-5D population value set: the case of Japan.

1 reference

12 December 2020

Primary staging of lymphomas: cost-effectiveness of FDG-PET versus computed tomography

1 reference

12 December 2020

Pharmacoeconomic consequences of variable patient compliance with prescribed drug regimens

1 reference

12 December 2020

Assessing the cost effectiveness of NSAID: an international perspective.

1 reference

12 December 2020

A tale of two (or more) cities: geographic transferability of pharmacoeconomic data.

1 reference

12 December 2020

Financial incentives in health care. The impact of performance-based reimbursement.

1 reference

12 December 2020

Variations between countries in invasive cardiac procedures and outcomes in patients with suspected unstable angina or myocardial infarction without initial ST elevation. OASIS (Organisation to Assess Strategies for Ischaemic Syndromes) Registry Inv

1 reference

12 December 2020

Resource costing for multinational neurologic clinical trials: methods and results.

1 reference

12 December 2020

Issues in the cross-national assessment of health technology

1 reference

12 December 2020

Are the WOSCOPS clinical and economic findings generalizable to other populations? A case study for Belgium. The WOSCOPS Economic Analysis Group. West of Scotland Coronary Prevention Study.

1 reference

12 December 2020

Randomised comparison of implantation of heparin-coated stents with balloon angioplasty in selected patients with coronary artery disease (Benestent II)

1 reference

12 December 2020

Evaluating the potential cost-effectiveness of stenting as a treatment for symptomatic single-vessel coronary disease. Use of a decision-analytic model

1 reference

12 December 2020

Analysis of the eligibility of published economic evaluations for transfer to a given health care system. Methodological approach and application to the French health care system

1 reference

12 December 2020

How cost-effective is breast cancer screening in different EC countries?

1 reference

12 December 2020

EuroQol: health-related quality of life measurement. Results of the Swedish questionnaire exercise

1 reference

12 December 2020

In-hospital and one-year economic outcomes after coronary stenting or balloon angioplasty. Results from a randomized clinical trial. Stent Restenosis Study Investigators

1 reference

12 December 2020

Economic evaluation and health care decision-making.

1 reference

12 December 2020

A comparison of the cost-effectiveness of stroke care provided in London and Copenhagen.

1 reference

12 December 2020

Learning and the evolution of medical technologies: the diffusion of coronary angioplasty

1 reference

12 December 2020

Work status and productivity costs due to ankylosing spondylitis: comparison of three European countries.

1 reference

12 December 2020

Design and analysis of unit cost estimation studies: How many hospital diagnoses? How many countries?

1 reference

12 December 2020

Managed care and technical efficiency

1 reference

12 December 2020

Variation in average costs among federally sponsored state-organized cancer detection programs: economies of scale?

1 reference

12 December 2020

In-hospital costs associated with new percutaneous coronary devices

1 reference

12 December 2020

Design, analysis and presentation of multinational economic studies: the need for guidance

1 reference

12 December 2020

The friction cost method for measuring indirect costs of disease.

1 reference

12 December 2020

Cross-national price differences for pharmaceuticals: how large, and why?

1 reference

12 December 2020

Association of volume with outcome of coronary artery bypass graft surgery. Scheduled vs nonscheduled operations

1 reference

12 December 2020

A multinational economic evaluation of rhDNase in the treatment of cystic fibrosis

1 reference

12 December 2020

Cost-effectiveness of a potential vaccine for human papillomavirus

1 reference

12 December 2020

Comparative model-based analysis of screening programs for Chlamydia trachomatis infections

1 reference

12 December 2020

Analysis of costs and cost-effectiveness in multinational trials

1 reference

12 December 2020

Costing intensive care services: a review of study methods, results and limitations

1 reference

12 December 2020

EuroQol: health-related quality of life measurement. Valuations of health states by the general public in Norway

1 reference

12 December 2020

International differences in health care costs in Europe and the United States: Do these affect the cost-effectiveness of diagnostic strategies for pulmonary embolism?

1 reference

12 December 2020

Cost-Effectiveness of Palmaz-Schatzª Stenting in Patients with Coronary Artery Disease in Germany

1 reference

12 December 2020

10.2165/00019053-200422130-00004

Identifiers

DOI

1 reference

13 May 2018

Dimensions Publication ID

1005077016

0 references

1 reference

13 May 2018